Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,760.00    0.00 (0.00%)
Bid:
2,770.00
Ask:
2,785.00
Spread: 15.00 (0.542%)
Market Cap: £2.16b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

19 Mar 2026 13:30

RNS Number : 3657X
Hill & Smith PLC
19 March 2026
 

19 March 2026

Hill & Smith PLC ('Hill & Smith' or the 'Company')Director and PDMR Shareholdings

Hill & Smith announces the following dealings by Directors and PDMRs of the Company in connection with its employee share plan arrangements.

Hill & Smith 2023 Long Term Incentive Plan - 2026 Award ('LTIP')

On 18 March 2026 (the 'Grant Date'), the Company granted awards under the Hill & Smith 2023 Long Term Incentive Plan to the Directors / PDMRs as set out below:

Director / PDMR

Name

Job Title

Type of award

Number of shares

Director

Rutger Helbing

Chief Executive Officer

Nil-cost option

57,935

Director

Chris McLeish

Chief Financial Officer

Nil-cost option

32,717

PDMR

Tim Tehan

Group President

Conditional award

20,053

PDMR

Nick Adcock

Group President

Nil-cost option

13,482

 

The number of shares over which the awards were granted was calculated based on a share price of £21.25, that being the closing mid-market price from the day immediately preceding the date of grant.

The Awards will vest based on the achievement of relative Total Shareholder Return (40%), Underlying EPS Growth (50%) and the Company's reduction in greenhouse gas emissions (10%) over a 3-year performance period. The detailed performance conditions will be provided in the 2026 Directors' Remuneration Report.

The Awards will (subject to the achievement of the performance conditions) vest following the end of the performance period, for Rutger Helbing and Chris McLeish the LTIP may not ordinarily be exercised until the end of a further two-year holding period.

Deferred Bonus Plan awards in respect of 2025 bonuses

On 18 March 2026 the Company granted awards under the rules of its Deferred Bonus Plan in respect of bonuses earned for the year ended 31 December 2025. The Company confirms that:

Director / PDMR

Name

Job Title

Type of award

Number of shares

Director

Rutger Helbing

Chief Executive Officer

Nil-cost option

19,365

Director

Chris McLeish

Chief Executive Officer

Nil-cost option

2,378

PDMR

Tim Tehan

Group President

Conditional award

3,335

PDMR

Nick Adcock

Group President

Nil-cost option

1,596

 

The awards will vest following the end of a two-year deferral period.

The Notification of Dealing Forms for the above transactions are set out below:

Notification of Dealing Form for Rutger Helbing

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Rutger Helbing

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

57,935

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost option under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

19,365

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Notification of Dealing Form for Chris McLeish

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

32,717

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

2,378

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Notification of Dealing Form for Tim Tehan

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Tim Tehan

2.

Reason for the notification

(a)

Position/status

Group President

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of a Conditional Award under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

20,053

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of a Conditional Award under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

3,335

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

 

Notification of Dealing Form for Nicholas Adcock

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Nick Adcock

2.

Reason for the notification

(a)

Position/status

Group President

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

13,482

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

1,596

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Enquiries:

Karen Atterbury

Company Secretary

0121 704 7430

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKCBDNBKDBND
Date   Source Headline
27th Nov 20204:38 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSTrading Update
10th Nov 20207:00 amRNSTotal Voting Rights
2nd Nov 20201:47 pmRNSTotal Voting Rights
13th Oct 20203:21 pmRNSDirector/PDMR Shareholding
1st Oct 20201:14 pmRNSDirector/PDMR Shareholding
1st Oct 20201:10 pmRNSTotal Voting Rights - Replacement
1st Oct 202012:52 pmRNSTotal Assets Value
1st Sep 20208:43 amRNSTotal Voting Rights
24th Aug 202012:39 pmRNSDirector/PDMR Shareholding
17th Aug 202012:44 pmRNSDirector/PDMR Shareholding
10th Aug 20204:14 pmRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSHalf Year Results
3rd Aug 202011:52 amRNSTotal Voting Rights
22nd Jul 202010:12 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20202:09 pmRNSTotal Voting Rights
25th Jun 20209:41 amRNSDirector/PDMR Shareholding
24th Jun 20201:21 pmRNSResult of AGM
17th Jun 20207:00 amRNSTrading Update
1st Jun 20202:29 pmRNSTotal Voting Rights
27th May 20203:10 pmRNSNotice of Trading Update
26th May 20207:00 amRNSAnnual Report and Notice
4th May 20202:26 pmRNSTotal Voting Rights
30th Apr 202010:54 amRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20202:21 pmRNSDirector/PDMR Shareholding
2nd Apr 20201:11 pmRNSTotal Voting Rights
2nd Apr 20207:00 amRNSBoard Appointment
27th Mar 20207:00 amRNSCOVID-19 Update
4th Mar 20207:00 amRNSFinal Results
2nd Mar 202010:33 amRNSTotal Voting Rights
3rd Feb 202011:48 amRNSTotal Voting Rights
29th Jan 20207:00 amRNSChange of Auditor 2020
22nd Jan 202012:26 pmRNSBLOCK LISTING SIX MONTHLY RETURN
13th Jan 20203:42 pmRNSDirector/PDMR Shareholding
6th Jan 20201:35 pmRNSTotal Voting Rights
10th Dec 20197:00 amRNSCapital Markets Day
3rd Dec 201910:28 amRNSTotal Voting Rights
2nd Dec 20197:00 amRNSBoard Appointments
21st Nov 20197:00 amRNSTrading Statement
6th Nov 20192:41 pmRNSDirector/PDMR Shareholding
1st Nov 20192:32 pmRNSTotal Voting Rights
2nd Oct 20193:14 pmRNSTotal Voting Rights
30th Sep 20197:00 amRNSAcquisition
2nd Sep 20191:10 pmRNSTotal Voting Rights
8th Aug 201910:24 amRNSDirector/PDMR Shareholding
7th Aug 20197:00 amRNSAppointment of Chairman
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 20192:21 pmRNSTotal Voting Rights
22nd Jul 20199:28 amRNSBlock listing Interim Review
3rd Jul 20192:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.